Search - tctmd.com

Displaying 281 - 300 of 386

Sort: Relevancy | Date

News Daily News

2014 Guideline for NSTE-ACS Management Has New Name, Focus

September 30, 2014

News Daily News

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

September 11, 2014

News Daily News

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

September 02, 2014

News Conference News ESC 2014

MITOCARE: Novel Drug as Adjunct to PCI for STEMI Does Not Reduce Reperfusion Injury Risk

Yael L. Maxwell

September 02, 2014

News Daily News

HORIZONS-AMI亚组研究：直接PCI后抗凝血产生的结果更差

September 02, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Conference News ESC 2014

Another Strike Against Thrombectomy in 1-Year TASTE Results

Todd Neale

September 02, 2014

News Conference News ESC 2014

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

Todd Neale

September 01, 2014

News Conference News ESC 2014

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

Caitlin E. Cox

September 01, 2014

News Conference News ESC 2014

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Yael L. Maxwell

September 01, 2014

News Conference News ESC 2014

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Yael L. Maxwell

August 31, 2014

News Conference News ESC 2014

Observational Studies Ask How Much Medication Adherence Matters After MI

Caitlin E. Cox

August 31, 2014

News Conference News ESC 2014

APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI

Yael L. Maxwell

August 31, 2014

News Conference News ESC 2014

Post-Acute MI Survival Improving for Elderly Patients in France

Todd Neale

August 30, 2014

News Daily News

Long-term Mortality Worse for Black vs White NSTEMI Patients, Linked with Treatment Discrepancies

July 17, 2014

News Daily News

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

July 08, 2014

News Daily News

Coronary Dominance Plays Role in Early Post-STEMI Mortality Risk

Yael L. Maxwell

June 24, 2014

News Daily News

Manual Thrombectomy Optimizes PCI, But No Long-term Benefit in STEMI

Yael L. Maxwell

June 03, 2014

News Conference News EuroPCR 2014

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

Yael L. Maxwell

May 21, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

Advertisement

2014 Guideline for NSTE-ACS Management Has New Name, Focus

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

MITOCARE: Novel Drug as Adjunct to PCI for STEMI Does Not Reduce Reperfusion Injury Risk

HORIZONS-AMI亚组研究：直接PCI后抗凝血产生的结果更差

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

Another Strike Against Thrombectomy in 1-Year TASTE Results

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

CvLPRIT: Complete Revascularization Halves MACE Risk in STEMI Patients

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Observational Studies Ask How Much Medication Adherence Matters After MI

APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI

Post-Acute MI Survival Improving for Elderly Patients in France

Long-term Mortality Worse for Black vs White NSTEMI Patients, Linked with Treatment Discrepancies

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

Coronary Dominance Plays Role in Early Post-STEMI Mortality Risk

Manual Thrombectomy Optimizes PCI, But No Long-term Benefit in STEMI

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content